09/10/2015 The results of the IARC Monographs evaluation for Volume 114 (red meat and processed meat) will be announced when the summary of the evaluations is published in The Lancet Oncology. The anticipated publication date is Monday 26 October 2015. See IARC Monographs Meetings
09/10/2015 As part of the celebrations of the 50th anniversary of the establishment of IARC, you are invited to tell us what IARC has meant to you over the years, for example in relation to research achievements, career development, or simply in terms of friendships formed. Provide your testimony
The mycotoxin aflatoxin B1 stimulates EpsteinBarr virus-induced B-cell transformation in in vitro and in vivo experimental models
A new study by researchers from the International Agency for Research on Cancer (IARC) and partners demonstrates in in vitro and in vivo experimental models that aflatoxin B1 (AFB1) stimulates the oncogenic potential of EpsteinBarr virus (EBV) infection. The findings, published in Carcinogenesis, also emphasize the possibility that AFB1 may contribute to other virus-associated cancers and identify an urgent need to seek new associations, particularly in Africa.
The mycotoxin aflatoxin B1 stimulates EpsteinBarr virus-induced B-cell transformation in in vitro and in vivo experimental models. Accardi R, Gruffat H, Sirand C, Fusil F, Gheit T, Hernandez-Vargas H, et al. Carcinogenesis. Published online 30 September 2015; http://dx.doi.org/10.1093/carcin/bgv142
International Agency for Research on Cancer: The First 50 Years, 1965-2015
Authors: Rodolfo Saracci and Christopher P. Wild
This book charts the birth of IARC during the 1960s - a period of great optimism for international cooperation and medical science. It goes on to describe the Agency's major achievements over the past five decades in terms of the development of tools for conducting cancer research, the identification of risk factors, and the evaluation of preventive interventions. Download the PDF or EPUB, Order at WHOPress